Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment.
Publication
, Journal Article
Rapaport, R; Rose, SR; Freemark, M
Published in: J Pediatr
August 2001
Duke Scholars
Published In
J Pediatr
DOI
ISSN
0022-3476
Publication Date
August 2001
Volume
139
Issue
2
Start / End Page
182 / 188
Location
United States
Related Subject Headings
- Thyroxine
- Thyrotropin
- Thyroid Gland
- Risk Factors
- Pediatrics
- Infant, Premature
- Infant, Newborn
- Hypothyroidism
- Humans
- 1114 Paediatrics and Reproductive Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Rapaport, R., Rose, S. R., & Freemark, M. (2001). Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr, 139(2), 182–188. https://doi.org/10.1067/mpd.2001.116934
Rapaport, R., S. R. Rose, and M. Freemark. “Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment.” J Pediatr 139, no. 2 (August 2001): 182–88. https://doi.org/10.1067/mpd.2001.116934.
Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr. 2001 Aug;139(2):182–8.
Rapaport, R., et al. “Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment.” J Pediatr, vol. 139, no. 2, Aug. 2001, pp. 182–88. Pubmed, doi:10.1067/mpd.2001.116934.
Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr. 2001 Aug;139(2):182–188.
Published In
J Pediatr
DOI
ISSN
0022-3476
Publication Date
August 2001
Volume
139
Issue
2
Start / End Page
182 / 188
Location
United States
Related Subject Headings
- Thyroxine
- Thyrotropin
- Thyroid Gland
- Risk Factors
- Pediatrics
- Infant, Premature
- Infant, Newborn
- Hypothyroidism
- Humans
- 1114 Paediatrics and Reproductive Medicine